Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
No open-market purchases or sales by Neurogene Inc. insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Neurogene Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 85 | +4 |
| Shares | 27.0M | 2.04M | 25.9M | +947.5K (+3.8%) |
| Value | $248.8M | $18.9M | $187.1M | −$42.8M (−18.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Neurogene Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 2,664,491 | $19.3M | 0.02% |
| Gsa Capital Partners LLP | 75,419 | $545.0K | 0.06% |
| HRT Financial LP | 52,893 | $382.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 26,159 | $189.0K | 0.00% |
| SG Americas Securities, LLC | 22,340 | $162.0K | 0.00% |
| PDT Partners, LLC | 20,774 | $150.0K | 0.01% |
| Marshall Wace, LLP | 19,421 | $140.0K | 0.00% |
| Signaturefd, LLC | 489 | $4.00K | 0.00% |
| US Bancorp | 164 | $1.00K | 0.00% |
| Ellevest, Inc. | 24 | $0 | 0.00% |
| Parallel Advisors, LLC | 53 | $0 | 0.00% |
| Lindbrook Capital, LLC | 39 | $0 | 0.00% |
Sold out (8)
Institutions that held Neurogene Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Rafferty Asset Management, LLC | 36,258 | $335.0K |
| Cerity Partners LLC | 31,000 | $286.0K |
| Qube Research & Technologies Ltd | 16,385 | $151.0K |
| DekaBank Deutsche Girozentrale | 14,000 | $129.0K |
| Change Path, LLC | 10,500 | $97.0K |
| State of Wyoming | 1,582 | $15.0K |
| Eaton Vance Management | 227 | $2.00K |
| Geneos Wealth Management Inc. | 215 | $2.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Neurogene Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 2,043,896 | $18.9M |